首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1605703

体载注射器市场，按技术、按应用、按最终用途、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

On-body Injectors Market, By Technology, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年12月01日 | 出版商:

AnalystView Market Insights | 英文 372 Pages | 商品交期: 2-3个工作天内

价格

简介目录

报告要点

2023 年，体载注射器市场规模为 48.97 亿美元，2024 年至 2032 年复合年增长率为 14.5%。

体载注射器市场-市场动态

慢性病盛行率上升推动市场成长

体上註射器市场是由糖尿病、类风湿性关节炎和癌症等慢性疾病盛行率上升所推动的，这些疾病需要持续用药。这些穿戴式装置使患者能够以最小的不适自行给药，从而提高依从性和便利性。技术进步，包括与用于监控和反馈的数位平台的集成，进一步促进了它们的采用。此外，向生物製剂和特殊药物的转变增加了对高效能药物传递系统（如体内註射器）的需求。老年人口不断增长、对微创解决方案的需求以及监管机构的支持等关键因素促进了市场的成长。

体载注射器市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 14.5% 左右的复合年增长率成长

根据技术细分，预计基于弹簧的细分市场将在 2023 年显示最大的市场份额

根据应用细分，类风湿性关节炎是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

体载注射器市场細項分析：

全球体上註射器市场根据技术、应用、最终用途和地区进行细分。自动注射器市场依技术主要分为两个部分：弹簧式、马达驱动式、旋转帮浦式和膨胀电池式等。基于弹簧的细分市场主导了市场。这些体内注射器为患者和医疗保健提供者提供了许多好处。透过以一致的压力和速度传递药物，它们可确保准确可靠的剂量，这对于需要精确度的治疗尤其重要，例如治疗糖尿病的胰岛素或治疗自体免疫疾病的生物製剂。这种机制最大限度地减少了与手动注射相关的错误可能性，提高了治疗安全性和效率。他们的控释系统也支持病患的舒适度和依从性，使其成为各种临床应用的首选。

基于应用：肿瘤学、糖尿病、心血管疾病、自体免疫疾病等。到 2023 年，糖尿病细分市场将占据最大的市场份额。在肿瘤学中，它们提供精确剂量的化疗药物，以最大限度地减少医院就诊次数。对于糖尿病，它们可确保控制胰岛素输送，为传统注射提供灵活的替代方案。在心血管疾病中，这些设备可以施用抗凝血剂或其他关键药物来有效控制病情。自体免疫疾病受益于定期生物治疗的体内注射器，减少了频繁临床就诊的需要。此外，它们也用于其他治疗领域，如疼痛管理和荷尔蒙治疗，提供可靠和个人化的给药解决方案。

根据最终用途，市场分为家庭护理场所、医院和诊所以及门诊手术中心。家庭护理设置细分市场占据主导地位。体内注射器在家庭护理环境中越来越受欢迎，因为它们允许患者安全、轻鬆地自行给药。这种便利性减少了频繁就诊的需要，使慢性病患者的治疗更容易、更有效率。这些设备在家庭护理领域的兴起是推动该领域快速成长的关键因素。

体载注射器市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。由于对自我给药药物系统的需求不断增加，特别是对于糖尿病和自体免疫疾病等慢性疾病的需求不断增加，体上註射器市场正在经历显着增长。在先进的医疗基础设施和创新技术的广泛采用的推动下，北美在市场上占据主导地位。在政府支持性措施和人口老化不断加剧的推动下，欧洲紧随其后。由于医疗保健投资的增加、患者群体的扩大以及对先进给药系统的认识的提高，亚太地区正在成为关键的成长地区。同时，中东、非洲和拉丁美洲呈现稳定成长，这主要得益于医疗保健服务的改善和基础设施的发展。

体载注射器市场-竞争格局：

身体注射器市场的竞争格局以领先的医疗保健和製药公司的存在为标誌，推动穿戴式药物输送系统的创新。 Medtronic plc、Insulet Corporation、Ypsomed 和 West Pharmaceutical Services 等主要参与者以专为慢性病管理量身定制的先进解决方案主导市场。其他着名公司，如 Enable Injections 和 Becton, Dickinson and Company (BD)，专注于精确、用户友好的设计以及与数位健康平台的整合。合作伙伴关係和收购进一步加剧了竞争，使公司能够扩大其产品组合併增强其技术能力，以满足全球不断增长的患者和医疗保健需求。

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美体内注射器主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按技术）
- 北美市场规模和预测（按应用）
- 北美市场规模和预测（按最终用途）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲体内注射器主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按技术）
- 欧洲市场规模和预测（按应用）
- 欧洲市场规模和预测（按最终用途）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区体载注射器主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按技术）
- 亚太地区市场规模与预测（按应用）
- 亚太地区市场规模和预测（按最终用途）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲注射器主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按技术）
- 拉丁美洲市场规模与预测（按应用）
- 拉丁美洲市场规模和预测（按最终用途）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲体内注射器主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按技术）
- 中东和非洲市场规模及预测（按应用）
- 中东和非洲市场规模和预测（按最终用途）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 体上註射器产业

竞争仪表板
- Competitive Benchmarking
- Competitive Positioning
公司简介
- Insulet Corporation
- BD (Becton, Dickinson and Company)
- West Pharmaceutical Services, Inc.
- Ypsomed Holding AG
- Medtronic plc
- Enable Injections
- Roche
- Eli Lilly and Company
- Amgen Inc.
- CeQur SA
- Others

第 12 章：360 度分析师视角

第 13 章：附录

研究方法
参考
缩写
免责声明
联络我们

简介目录

Product Code: ANV4319

REPORT HIGHLIGHT

On-body Injectors Market size was valued at USD 4,897 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

On-body Injectors are wearable drug delivery devices designed to administer medications subcutaneously over a specific period, offering convenience and precision in chronic disease management. These devices enable self-administration of large-volume biologics and improve patient compliance by reducing the need for frequent hospital visits. With advanced features like programmable dosing, they cater to treatments for conditions such as diabetes, rheumatoid arthritis, and cancer. On-body injectors integrate cutting-edge technology to ensure ease of use, patient comfort, and safety, making them a significant innovation in personalized medicine and home-based healthcare solutions.

On-body Injectors Market- Market Dynamics

Rising prevalence of chronic diseases to fuel market growth

The on-body injectors market is driven by the rising prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and cancer, which require consistent drug administration. These wearable devices enable patients to self-administer medication with minimal discomfort, improving adherence and convenience. Technological advancements, including integration with digital platforms for monitoring and feedback, further boost their adoption. Additionally, the shift toward biologics and specialty medications has increased the need for efficient drug delivery systems like on-body injectors. Key factors such as the growing geriatric population, demand for minimally invasive solutions, and support from regulatory bodies foster the market's growth.

On-body Injectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on Technology segmentation, spring-based segment were predicted to show maximum market share in the year 2023

Based on Application segmentation, rheumatoid arthritis was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

On-body Injectors Market- Segmentation Analysis:

The Global On-body Injectors Market is segmented on the basis of Technology, Application, End-Use, and Region. The auto-injector market is primarily divided into two segments based on Technology: Spring-based, Motor-driven, Rotary Pump and Expanding Battery and Other. The spring-based segment dominated the market. These on-body injectors offer numerous benefits to patients and healthcare providers. By delivering medication at consistent pressure and speed, they ensure accurate and reliable dosing, which is particularly essential for therapies requiring precision, such as insulin for diabetes or biologics for autoimmune diseases. This mechanism minimizes the potential for errors associated with manual injections, enhancing treatment safety and efficiency. Their controlled delivery system also supports patient comfort and compliance, making them a preferred choice in various clinical applications.

Based on application into: Oncology, Diabetes, Cardiovascular Disease, Autoimmune Disease and Others. The diabetes segment accounted for the largest market share in 2023. On-body injectors are wearable drug delivery devices designed to administer medications over an extended period, enhancing patient convenience and compliance. In oncology, they deliver precise doses of chemotherapy drugs, minimizing hospital visits. For diabetes, they ensure controlled insulin delivery, providing a flexible alternative to traditional injections. In cardiovascular diseases, these devices administer anticoagulants or other critical drugs to manage conditions effectively. Autoimmune diseases benefit from on-body injectors for regular biologic therapies, reducing the need for frequent clinical visits. Additionally, they are used in other therapeutic areas like pain management and hormone therapies, offering reliable and personalized drug administration solutions.

Based on end-use the market is segmented as Homecare Settings, Hospitals & Clinics and Ambulatory Surgical Centers. The homecare settings segment dominated the market. On-body Injectors are increasingly popular in homecare settings, as they allow patients to safely and easily administer their medications on their own. This convenience reduces the need for frequent healthcare visits, making treatments more accessible and efficient for individuals managing chronic conditions. The rise of these devices in homecare is a key factor contributing to the segment's rapid growth.

On-body Injectors Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The on-body injectors market is experiencing significant growth due to increasing demand for self-administration drug systems, particularly for chronic diseases such as diabetes and autoimmune conditions. North America dominates the market, driven by advanced healthcare infrastructure and high adoption of innovative technologies. Europe follows closely, fueled by supportive government initiatives and a growing aging population. The Asia-Pacific region is emerging as a key growth area due to rising healthcare investments, expanding patient pools, and increased awareness about advanced drug delivery systems. Meanwhile, the Middle East & Africa and Latin America exhibit steady growth, primarily due to improving healthcare access and infrastructure development.

On-body Injectors Market- Competitive Landscape:

The competitive landscape of the on-body injectors market is marked by the presence of leading healthcare and pharmaceutical companies driving innovation in wearable drug delivery systems. Key players like Medtronic plc, Insulet Corporation, Ypsomed, and West Pharmaceutical Services dominate the market with advanced solutions tailored for chronic disease management. Other notable companies, such as Enable Injections and Becton, Dickinson and Company (BD), focus on precision, user-friendly designs, and integration with digital health platforms. The competition is further fueled by partnerships and acquisitions, enabling companies to expand their portfolios and enhance their technological capabilities to meet growing patient and healthcare demands globally.

Recent Developments:

In February 2024, Coherus BioSciences, Inc. launched its UDENYCA ONBODY, a novel wearable injector for delivering pegfilgrastim, which reduces infection risk during chemotherapy. The device enhances patient convenience by minimizing hospital visits.

In October 2023, the U.S. FDA approved the Empaveli Injector, an on-body injector for the self-administration of pegcetacoplan. This device allows patients to administer their health irrespective of their location.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ON-BODY INJECTORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Insulet Corporation
BD (Becton, Dickinson and Company)
West Pharmaceutical Services, Inc.
Ypsomed Holding AG
Medtronic plc
Enable Injections
Roche
Eli Lilly and Company
Amgen Inc.
CeQur SA
Others

GLOBAL ON-BODY INJECTORS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Spring-based
Motor-driven
Rotary Pump
Expanding Battery
Other

GLOBAL ON-BODY INJECTORS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Oncology
Diabetes
Cardiovascular Disease
Autoimmune Disease
Others

GLOBAL ON-BODY INJECTORS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Hospitals & Clinics
Home Care Settings
Others

GLOBAL ON-BODY INJECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. On-body Injectors Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. On-body Injectors Market Snippet by Technology
- 2.1.2. On-body Injectors Market Snippet by Application
- 2.1.3. On-body Injectors Market Snippet by End-Use
- 2.1.4. On-body Injectors Market Snippet by Country
- 2.1.5. On-body Injectors Market Snippet by Region
2.2. Competitive Insights

3. On-body Injectors Key Market Trends

3.1. On-body Injectors Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. On-body Injectors Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. On-body Injectors Market Opportunities
3.4. On-body Injectors Market Future Trends

4. On-body Injectors Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. On-body Injectors Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. On-body Injectors Market Landscape

6.1. On-body Injectors Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. On-body Injectors Market - By Technology

7.1. Overview
- 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
- 7.1.2. Spring-based
- 7.1.3. Motor-driven
- 7.1.4. Rotary Pump
- 7.1.5. Expanding Battery
- 7.1.6. Other

8. On-body Injectors Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Oncology
- 8.1.3. Diabetes
- 8.1.4. Cardiovascular Disease
- 8.1.5. Autoimmune Disease
- 8.1.6. Others

9. On-body Injectors Market - By End-Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
- 9.1.2. Homecare Settings
- 9.1.3. Hospitals & Clinics
- 9.1.4. Ambulatory Surgical Centers

10. On-body Injectors Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. On-body Injectors Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. On-body Injectors Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. On-body Injectors Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. On-body Injectors Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. On-body Injectors Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- On-body Injectors Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Insulet Corporation
- 11.2.2. BD (Becton, Dickinson and Company)
- 11.2.3. West Pharmaceutical Services, Inc.
- 11.2.4. Ypsomed Holding AG
- 11.2.5. Medtronic plc
- 11.2.6. Enable Injections
- 11.2.7. Roche
- 11.2.8. Eli Lilly and Company
- 11.2.9. Amgen Inc.
- 11.2.10. CeQur SA
- 11.2.11. Others